Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bictegravir (Biktarvy) (1 trial)
dolutegravir (tivicay) (1 trial)
emtricitabine (emtriva) (2 trials)
fostemsavir (Rukobia) (1 trial)
lamivudine (epivir) (3 trials)
tenofovir alafenamide (genvoya) (1 trial)
ad26.mos.hiv (1 trial)
elvucitabine (3 trials)
mva-bn-hiv (1 trial)
pgdm1400 (2 trials)
pgt121 (2 trials)
vrc07-523ls (2 trials)
pro-140 monoclonal antibody (1 trial)
HIV Infections (Phase 2)
Infections (Phase 2)
Trials (8 total)
Trial APIs (13 total)